GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation

Non-small cell lung cancer (NSCLC) is a serious threat to human health, and 40%–80% of NSCLCs express high levels of epidermal growth factor receptor (EGFR). GE11 is a novel peptide and exhibits high affinity for EGFR binding. The aim of this study was to construct and evaluate GE11-modified liposom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Liang, Huang, Fa-Zhen, Cheng, Li-Fang, Zhu, Ya-Qin, Hu, Qing, Li, Ling, Wei, Lin, Chen, Da-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928463/
https://www.ncbi.nlm.nih.gov/pubmed/24611009
http://dx.doi.org/10.2147/IJN.S53310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928463/
https://www.ncbi.nlm.nih.gov/pubmed/24611009
http://dx.doi.org/10.2147/IJN.S53310

Ejemplares similares